Skip to Content

CFZ 300 (Invokana 300 mg)

Generic Name: canagliflozin

Pill with imprint CFZ 300 is White, Capsule-shape and has been identified as Invokana 300 mg. It is supplied by Janssen Pharmaceuticals, Inc..

Invokana is used in the treatment of diabetes, type 2; diabetic kidney disease; cardiovascular risk reduction and belongs to the drug class SGLT-2 inhibitors. Risk cannot be ruled out during pregnancy. Invokana 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for CFZ 300

Invokana 300 mg CFZ 300
Invokana 300 mg CFZ 300
Invokana 300 mg CFZ 300 Front
Invokana 300 mg CFZ 300 Back
Invokana 300 mg CFZ 300

Invokana

Generic Name
canagliflozin
Imprint
CFZ 300
Strength
300 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
SGLT-2 inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Janssen Pharmaceuticals, Inc.
National Drug Code (NDC)
50458-0141

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.